No Improvement in OS or PFS from Sacituzumab Govitecan Compared with Chemotherapy In Pretreated Patients with Advanced Urothelial Cancer By Ogkologos - March 24, 2025 958 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TROPiCS-04 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR “Selfless and Incredible” Mother Leaves Behind Five Children After Battling Breast... November 25, 2020 EMA Recommends Extending Indications for Decitabine / Cedazuridine May 29, 2026 Woman Finds Out She Has Breast Cancer From Museum Photo Booth November 1, 2019 Treatment for Children with Leukemia Also Effective for Adolescents, Young Adults February 25, 2019 Load more HOT NEWS Tackling under-representation of Black data scientists in cancer research Qué debo saber sobre la mastectomía con cierre plano después de... What Is Peripheral Neuropathy and How Can It Be Prevented or... What Hodgkin Lymphoma Survivors Should Know About Mantle Radiation and Breast...
